Stay Informed on Corporate Sustainability

Author: Archie Villaflores

Belfast-based drug discovery company AMPLY Discovery has secured strategic investment from South Korean biotech firm Keeps Biomed. The partnership strengthens Northern Ireland's pharmaceutical manufacturing excellence capabilities and advances AI-driven oncology drug development.

Author: Archie Villaflores

Pharmaceutical sector growth is shaped by strategic acquisitions and research partnerships that extend commercial portfolios whilst strengthening supply chain resilience. Narcolepsy treatment consolidation, award recognition documentation, and medicinal plant collaboration converge to demonstrate sector dynamism. First, 'Pharma Industry Awards 2025 Book of the Night captures a defining evening for Irish pharma' preserves achievement narratives including AbbVie Ireland's dual category wins and Deciphex's AI-powered innovation recognition. This commemorative publication establishes benchmarks as the sector advances toward the upcoming 2026 awards. Additionally, 'Alkermes completes $2.3 billion acquisition of Avadel Pharmaceuticals' demonstrates how Irish biopharmaceutical companies consolidate commercial portfolios through cash-and-debt transactions adding FDA-approved narcolepsy treatments. Strategic acquisitions accelerate market entry whilst leveraging estimated populations of oxybate-eligible patients across significant growth opportunities. Meanwhile, 'BauerTek partners with Rizal Technological University on medicinal plant production' reflects how pharmaceutical manufacturers establish academic cultivation partnerships to secure traceable raw materials for supplement operations. Research collaboration optimises growing conditions and extraction processes whilst supporting knowledge transfer between industry and academia. These stories frame a sector where acquisition strategy, achievement documentation, and supply chain innovation determine competitive advantage. Explore each article to understand how acquisitions and partnerships are advancing pharmaceutical sector positioning.

Author: Jed Nykolle Harme

The official post-event publication from Ireland's prestigious Pharma Industry Awards 2025 recognition programme is now available to read.

Author: Archie Villaflores

Ireland-based biotech company Aerska has raised $39 million in Series A funding to advance brain shuttle technology for delivering RNA medicines across the blood-brain barrier for neurological diseases.

Author: Archie Villaflores

Malaysia-based Duopharma Biotech has secured a government contract valued at approximately RM65.08 million (€14.08 million) to supply recombinant human insulin formulations to the Ministry of Health.

Author: Archie Villaflores

Philippines-based BauerTek Pharmaceutical Technologies has signed a memorandum of agreement with Rizal Technological University for strategic collaboration in medicinal plant research and production.

Author: Archie Villaflores

Denmark-based Novo Nordisk plans to expand its Athlone facility in Ireland to manufacture weight loss drug Wegovy for non-US markets, chief executive Mike Doustdar has confirmed to Bloomberg.

Author: Archie Villaflores

Ireland-based Alkermes has completed its $2.3 billion acquisition of Avadel Pharmaceuticals, adding FDA-approved narcolepsy treatment LUMRYZ to its commercial portfolio and accelerating entry into the sleep medicine market.

Author: Archie Villaflores

Pharmaceutical innovation reflects AI integration and strategic partnership models that compress development timelines whilst expanding market access. Progress emerges where diagnostic technology, distribution infrastructure, and computational drug discovery converge to strengthen commercial outcomes and patient impact. Revisiting a standout moment from last year, 'Deciphex wins Innovation of the Year at Pharma Industry Awards 2025' celebrates how AI-powered pathology platforms deliver measurable clinical impact through diagnostic workflow optimisation. This recognition establishes expectations for the 2026 awards, where real-world patient outcomes and operational scale will distinguish winning healthcare technologies. In addition, 'Bioreve Sciences secures nationwide retail partnership with Uniphar Group' demonstrates how Irish manufacturers leverage distribution agreements to expand market reach. Strategic retail partnerships enable supplement producers to scale domestic presence whilst maintaining supply chain control. Meanwhile, 'Takeda partners with Iambic on $1.7 billion AI drug discovery programme' illustrates how pharmaceutical companies deploy AI-driven molecular design platforms to compress preclinical timelines and reduce development costs. Multi-billion dollar partnerships validate computational approaches that predict protein binding and accelerate compound optimisation. These stories underscore a sector where technological capability, commercial infrastructure, and partnership strategy determine competitive advantage. Explore each article to understand how technology and collaboration are reshaping pharmaceutical sector performance.

Author: Archie Villaflores

Awarded for pioneering AI-powered diagnostics in 2025, Deciphex won Innovation of the Year at the Pharma Industry Awards, setting new standards for intelligent healthcare as the 2026 awards cycle approaches.